Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Respiratory Failure
•
Hospital Medicine
What factors do you consider while selecting high risk patients for prophylactic NIV after planned extubation?
Answer from: at Academic Institution
I use prophylactic NIV in severe Cardiomyopathy/CHF, severe COPD, and Obesity hypoventilation.
Sign in or Register to read more
20611
Related Questions
What has been your stepwise approach to oxygenation, including when to consider the use of inhaled nitric oxide or epoprostenol, in refractory hypoxemia due to cardiogenic pulmonary edema in patients who are otherwise not ECMO candidates?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Is there a subset of patients in whom pre-oxygenation with NRB or BVM could be safely pursued?
What are first-line choices for vasopressors/inotropes to use in hypotensive patients with Eisenmenger Syndrome?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
Does the experience level of the intubation operator affect outcomes related to pre-oxygenation with NIV versus an oxygen mask?
How do you use cardiac POCUS to potentially defer formal echocardiogram in patients presenting with an acute pulmonary embolism?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
Do you routinely perform echocardiography in patients with Staphylococcus aureus bacteremia deemed low risk for metastatic infection, or do you selectively omit it based on specific clinical criteria?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?